₹ 1.2 Cr
Volume transacted
10.3 K
stocks traded
Last Updated time: 19 Sep 9.00 AM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
19 Sep 2024 | 1146.5 | 1212 | 1212 | 1133.55 |
18 Sep 2024 | 1188.75 | 1217.4 | 1223.3 | 1180 |
17 Sep 2024 | 1200.4 | 1190 | 1222.75 | 1187.3 |
16 Sep 2024 | 1182.3 | 1202.15 | 1224.7 | 1176.85 |
13 Sep 2024 | 1208.55 | 1239.65 | 1239.65 | 1200.8 |
12 Sep 2024 | 1216.4 | 1241 | 1277 | 1211.55 |
11 Sep 2024 | 1248.6 | 1242.6 | 1252.75 | 1212 |
10 Sep 2024 | 1243.25 | 1200.6 | 1250.2 | 1168.55 |
09 Sep 2024 | 1204.15 | 1101.05 | 1218 | 1101.05 |
06 Sep 2024 | 1107.65 | 1158.05 | 1174 | 1100.9 |
Date | Price |
---|---|
19 Sep 2024 | 1146.5 |
18 Sep 2024 | 1188.75 |
17 Sep 2024 | 1200.4 |
16 Sep 2024 | 1182.3 |
13 Sep 2024 | 1208.55 |
12 Sep 2024 | 1216.4 |
11 Sep 2024 | 1248.6 |
10 Sep 2024 | 1243.25 |
09 Sep 2024 | 1204.15 |
06 Sep 2024 | 1107.65 |
Alembic Pharmaceuticals appoints Head - Technical Operations (Sterile & Oncology)
Alembic Pharmaceuticals has appointed Sudhakar Pandiyan as Head - Technical Operations (St...
Read more
16 Sep 202417:45
Alembic Pharmaceuticals receives USFDA final approval for Albendazole Tablets
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration...
Read more
05 Sep 202413:21
Alembic Pharma gains after receiving USFDA nod for Betamethasone Valerate Foam
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...
Read more
26 Aug 202409:55
Alembic Pharmaceuticals receives USFDA approval for Betamethasone Valerate Foam
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration...
Read more
24 Aug 202414:03
Alembic Pharma gets USFDA nod for Betamethasone Valerate Foam
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...
Read more
24 Aug 202416:59
Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration...
Read more
13 Aug 202412:15
Concalls
Feb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptFeb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptFAQs for EPS of Alembic Pharmaceuticals Ltd
On what factors does the shareholding pattern of Alembic Pharmaceuticals Ltd change frequently?
How often is Alembic Pharmaceuticals Ltd's shareholding pattern updated?
What categories are included in the shareholding pattern of Alembic Pharmaceuticals Ltd?
Why is the shareholding pattern of Alembic Pharmaceuticals Ltd important for investors?
Where can I find the latest shareholding pattern of Alembic Pharmaceuticals Ltd?
Unlimited trading at just
Rs. 199*